Envestnet Asset Management Inc. Trims Stock Holdings in Tenet Healthcare Corporation $THC

Envestnet Asset Management Inc. reduced its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 2.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 163,460 shares of the company’s stock after selling 4,867 shares during the quarter. Envestnet Asset Management Inc. owned 0.19% of Tenet Healthcare worth $33,189,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in THC. Hantz Financial Services Inc. raised its stake in shares of Tenet Healthcare by 35.4% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,852 shares of the company’s stock valued at $579,000 after purchasing an additional 746 shares in the last quarter. Westside Investment Management Inc. lifted its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares during the last quarter. Cornerstone Planning Group LLC grew its position in shares of Tenet Healthcare by 12,566.7% in the 3rd quarter. Cornerstone Planning Group LLC now owns 380 shares of the company’s stock worth $77,000 after acquiring an additional 377 shares in the last quarter. WCM Investment Management LLC raised its holdings in shares of Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares during the period. Finally, Peak Retirement Planning Inc. boosted its stake in Tenet Healthcare by 32.5% in the third quarter. Peak Retirement Planning Inc. now owns 11,821 shares of the company’s stock valued at $2,400,000 after acquiring an additional 2,899 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 earnings beat and revenue acceleration — Tenet reported $4.70 EPS vs. consensus ~ $4.05 and revenue rose ~8.9% year‑over‑year (~$5.53B), driven by hospital and ambulatory surgery demand. Tenet Healthcare Profit Rises on Ambulatory and Hospital Revenue Growth
• Positive Sentiment: Raised/clear FY‑2026 targets and EBITDA range — Management provided 2026 EPS guidance and an adjusted‑EBITDA target ($4.485B–$4.785B), signaling confidence in continued margin expansion and cash flow. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target
• Positive Sentiment: Management commentary and investor materials emphasize structural cost initiatives and M&A as levers to sustain growth and margins, reinforcing the outlook. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Market reaction — Coverage notes the stock hit record highs and traded on heavy volume after the release, indicating broad investor enthusiasm. Tenet Healthcare stock rises after Q4 beat
• Neutral Sentiment: Full‑year guidance range vs. consensus — Tenet gave an EPS range (16.19–18.47) and revenue range ($21.5B–$22.3B) that broadly brackets analyst expectations; midpoint is roughly close to consensus but leaves room for execution risk. Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook
• Negative Sentiment: Earlier concerns about patient‑day trends — Pre‑earnings commentary flagged that lower hospital patient days could pressure margins if the trend extended; investors will watch operating metrics closely in coming quarters. Will Lower Patient Days Affect Tenet Healthcare’s Q4 Earnings?

Wall Street Analyst Weigh In

Several analysts recently issued reports on THC shares. Royal Bank Of Canada raised their price target on Tenet Healthcare from $252.00 to $253.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. Mizuho raised their target price on Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, October 17th. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a research report on Wednesday, January 7th. JPMorgan Chase & Co. boosted their target price on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Finally, Barclays boosted their price objective on Tenet Healthcare from $229.00 to $240.00 and gave the stock an “overweight” rating in a research report on Friday, November 21st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $233.88.

Insiders Place Their Bets

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of THC opened at $225.86 on Thursday. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $229.00. The stock has a market capitalization of $19.85 billion, a P/E ratio of 15.48, a P/E/G ratio of 0.82 and a beta of 1.44. The firm’s 50 day moving average is $198.00 and its 200-day moving average is $193.90. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.64.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.05 by $0.65. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. During the same period last year, the business earned $3.44 EPS. The business’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.